PT  - JOURNAL ARTICLE
AU  - Helwick, Caroline
ED  - Antman, Elliott
TI  - Comparison of Prasugrel and Clopidogrel for Patients Undergoing PCI for ACS
DP  - 2007  01
TA  - MD Conference Express
PG  - 10--11
VI  - 7
IP  - 7
4099  - http://mdc.sagepub.com/content/7/7/10.short
4100  - http://mdc.sagepub.com/content/7/7/10.full
AB  - More potent antiplatelet therapy with prasugrel reduced the rate of ischemic events compared with clopidogrel among patients with acute coronary syndromes with planned percutaneous coronary intervention (PCI). The TRITON-TIMI 38 Trial showed that patients treated with the novel thienopyridine prasugrel had a significant net clinical benefit compared with clopidogrel, the standard therapy for patients undergoing PCI.